The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.
In an interview about the efficacy of COVID-19 vaccines, institute director Richard Marlink responds to public opinion about the differences among vaccines that are authorized or in the pipeline for use in the United States.
In a television interview broadcast by NJ Spotlight News, institute director Richard Marlink discusses the COVID-19 vaccine. Topics include how long immunity might last and roadblocks in rolling out a vaccination program.
In an interview about COVID-19 vaccines, institute director Richard Marlink discusses that people may need to get vaccinated annually as well as the importance of a global approach to controlling the pandemic.
